BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 24, 2015
View Archived Issues
Evestra receives convertible loan from Gedeon Richter to fund women's health pipeline
Read More
Palatin Technologies presents concordance analysis of diagnostic criteria for female sexual disorder
Read More
Study tests effects of alprostadil cream on genital blood flow
Read More
New softgel capsule technology provides better patient experience
Read More
Anti-MAdCAM antibody efficacy results for ulcerative colitis and Crohn's disease
Read More
Celimmune founded to develop new therapeutics for celiac and other autoimmune diseases
Read More
Eli Lilly and Incyte report phase III data for baricitinib in rheumatoid arthritis
Read More
Arrowhead begins phase I trial of ARC-AAT
Read More
Rindopepimut receives FDA breakthrough therapy designation in glioblastoma
Read More
Novocure enrolls first patient in phase II STELLAR trial
Read More
Foundation Medicine and H3 Biomedicine to develop precision therapies for cancer
Read More
FDA approves Dymista for use in children with seasonal allergic rhinitis
Read More
New guanylyl cyclase activators disclosed by Bayer
Read More
Rigel and BMS collaborate on TGF-beta receptor inhibitors for cancer
Read More
Gruenenthal divulges novel PDE4B inhibitors
Read More
Merck & Co. patents new ROMK channel blockers
Read More
Retrospective analysis shows overall survival benefit for ThermoDox in a subgroup of HCC patients
Read More
Sunshine Lake Pharma discloses new 5-HT reuptake inhibitors
Read More
Boehringer Ingelheim presents new ROR-gamma modulators
Read More
PMO targeting Ebola virus VP24 protects nonhuman primates
Read More
Takeda to acquire select portfolio from Neutec
Read More
FDA approves Novartis's panobinostat for multiple myeloma
Read More
ValiRx reports preliminary results from a phase I/II trial of VAL-201 in men with prostate cancer
Read More
FDA accepts Taiho's NDA for TAS-102 for refractory metastatic colorectal cancer
Read More